The DOI matches its Crossref record; 140 of the 141 references it cites were found in a registry or an index.
Anaphylaxis as a Clinical Manifestation of Clonal Mast Cell Disorders
Abstract
Clonal mast cell disorders comprise a heterogeneous group of disorders characterized by the presence of gain of function KIT mutations and a constitutively altered activation-associated mast cell immunophenotype frequently associated with clinical manifestations related to the release of mast cells mediators. These disorders do not always fulfil the World Health Organization (WHO)-proposed criteria for mastocytosis, particularly when low-sensitive diagnostic approaches are performed. Anaphylaxis is a frequent presentation of clonal mast cell disorders, particularly in mastocytosis patients without typical skin lesions. The presence of cardiovascular symptoms, e.g., hypotension, occurring after a hymenoptera sting or spontaneously in the absence of cutaneous manifestations such as urticaria is characteristic and differs from the presentation of anaphylaxis in the general population without mastocytosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Rather, MC typing is recommended as a diagnostic approach to diagnose or exclude SM in patients with MCA or MCAS (56-58).”
From Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome (2019) · cites this paper as [58]
In the citing paper
“Additionally, greater than 50% of patients experience severe anaphylaxis, especially in reaction to Hymenoptera venom (59, 60).”
From Defining “Normal” basal serum tryptase levels: a context-dependent approach to improve diagnostics in systemic mastocytosis (2025) · cites this paper as [60]
Citations
Cites
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
Swerdlow, S. H. (2017) · Medical Entomology and Zoology · Cited by 12,933
WHO classification of haematolymphoid tumours
Gaillard, F., Weerakkody, Y., & Sharma, R. (2010) · Radiopaedia.org · doi:10.53347/rid-9250 · Cited by 3,776
Johansson, S. G. O., Bieber, T., Dahl, R., Friedmann, P. S., Lanier, B. Q., Lockey, R. F., Motala, C., Ortega Martell, J. A., Platts-Mills, T. A. E., Ring, J., et al. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.12.591 · Cited by 2,391 · cited 4×
“The frequency of anaphylaxis is much lower in patients with ISM who have skin lesions (ISMs) (25 %), while a significant percentage of these ISMs patients display chronic MC mediator-related symptoms without fulfilling the criteria for anaphylaxis [19]. The first case of fatal anaphylaxis in a SM patient who suffered…”
InfluentialSampson, H. A., Muñoz-Furlong, A., Campbell, R. L., Adkinson, N. F., Bock, S. A., Branum, A., Brown, S. G. A., Camargo, C. A., Cydulka, R., Galli, S. J., et al. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.12.1303 · Cited by 2,313
Nagata, H., Worobec, A. S., Oh, C. K., Chowdhury, B. A., Tannenbaum, S., Suzuki, Y., & Metcalfe, D. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10560 · Cited by 872
Current Protocols in Cytometry
(2001) · John Wiley & Sons, Inc. eBooks · doi:10.1002/0471142956 · Cited by 862
Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis
Schwartz, L. B., Metcalfe, D. D., Miller, J. S., Earl, H., & Sullivan, T. (1987) · New England Journal of Medicine · doi:10.1056/nejm198706253162603 · Cited by 784
Valent, P., Akin, C., Escribano, L., Födinger, M., Hartmann, K., Brockow, K., Castells, M., Sperr, W. R., Kluin‐Nelemans, H. C., Hamdy, N. A. T., et al. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01807.x · Cited by 750
Self-citationSampson, H. A., Muñoz-Furlong, A., Campbell, R. L., Adkinson, N. F., Allan Bock, S., Branum, A., Brown, S. G. A., Camargo, C. A., Cydulka, R., Galli, S. J., et al. (2006) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2006.01.018 · Cited by 748
The diagnosis and management of anaphylaxis practice parameter: 2010 Update
Lieberman, P., Nicklas, R. A., Oppenheimer, J., Kemp, S. F., Lang, D. M., Bernstein, D. I., Bernstein, J. A., Burks, A. W., Feldweg, A. M., Fink, J. N., et al. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.06.022 · Cited by 739
Research works printed but not linked: 3
- Jara-Acevedo M, Garca-Montero A, Teodosio C, Escribano L, Alvarez-Twose I, Sanchez-Munoz L, et al. Well-differentiated systemic mastocytosis (WDSM): a novel form of mastocytosis. Haematologica. 2008;93:91.
- Sanchez-Matas I, Matito A, Gonzalez de Olano D, Alvarez-Twose I, Sanchez-Munoz L, de la Hoz Caballer B, et al. Prevalence of hypersensitivity reactions to nonsteroidal anti-inflamatory drugs in 212 patients with mastocytosis in Spain. Allergy. 2009;64:574–5.
- Matito A, Bartolome-Zavala B, Alvarez-Twose I, Sanchez-Matas I, Escribano L. IgE-mediated anaphylaxis to Hippobosca equina in a patient with systemic mastocytosis. Allergy. 2009;65:1058–9. · DOI
Cited by
Hartmann, K., Escribano, L., Grattan, C., Brockow, K., Carter, M. C., Alvarez-Twose, I., Matito, A., Broesby-Olsen, S., Siebenhaar, F., Lange, M., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.08.034 · Cited by 394
Self-citationProposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome
Valent, P., Akin, C., Bonadonna, P., Hartmann, K., Brockow, K., Niedoszytko, M., Nedoszytko, B., Siebenhaar, F., Sperr, W. R., Oude Elberink, J. N. G., et al. (2019) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2019.01.006 · Cited by 225
“Rather, MC typing is recommended as a diagnostic approach to reveal or exclude the presence of SM in patients with MCA or MCAS.(56-58)”
BackgroundMuraro, A., Lemanske, R. F., Castells, M., Torres, M., Khan, D., Simon, H. ‐., Bindslev-Jensen, C., Burks, W., Poulsen, L. K., Sampson, H. A., et al. (2017) · Allergy · doi:10.1111/all.13132 · Cited by 226
“presenting with hypotension are at increased risk of an underlying clonal mast cell disorder (systemic mastocytosis) (119, 124).”
BackgroundValent, P., Akin, C., Hartmann, K., Nilsson, G., Reiter, A., Hermine, O., Sotlar, K., Sperr, W. R., Escribano, L., George, T. I., et al. (2020) · Theranostics · doi:10.7150/thno.46719 · Cited by 180
“The features and severity of reactions evoked by MC activation depend on additional factors, such as the type and amounts of mediators released and the number and location of reacting MCs (and other immune cells including basophils) involved in the response [166, 167].”
BackgroundInfluentialSelf-citationValent, P., Akin, C., Gleixner, K. V., Sperr, W. R., Reiter, A., Arock, M., & Triggiani, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122976 · Cited by 93
Metadata
- Authors
- Matito, A., Alvarez-Twose, I., Morgado, J. M., Sánchez-Muñoz, L., Orfao, A., & Escribano, L.
- Affiliations
- Hospital Virgen del Valle (ES)
- Universidad de Salamanca (ES)
- Corresponding author
- Escribano, L.
- Venue
- Current Allergy and Asthma Reports
- Published
- 2014-06-20
- Volume
- 14
- Issue
- 8
- Pages
- 450-450
- ISSN
- 1529-7322 (ISSN-L)
- 1534-6315
- OpenAlex
- W2033726965
- Cited by
- 51
- References
- 141
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 3 · 2023: 3 · 2022: 2 · 2021: 6 · 2020: 8 · 2019: 5 · 2018: 5 · 2017: 4 · 2016: 3 · 2015: 9
- FWCI
- 0.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Current Allergy and Asthma Reports (publishedVersion)
- PubMed (publishedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
- Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
- Health Sciences › Medicine › Rheumatology › Eosinophilic Disorders and Syndromes
- Keywords
- anaphylaxis, clonal mast cell disorders, mastocytosis, KIT mutations, gain-of-function mutations, mast cell mediators, cardiovascular symptoms, hypotension, hymenoptera stings, urticaria
- MeSH terms
- Anaphylaxis, Humans, Mast Cells, Mastocytosis, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Anaphylaxis as a Clinical Manifestation of Clonal Mast Cell Disorders. https://app.cochat.ai/papers/10.1007/s11882-014-0450-8
- The paper
- Matito, A., Alvarez-Twose, I., Morgado, J. M., Sánchez-Muñoz, L., Orfao, A., & Escribano, L. (2014). Anaphylaxis as a Clinical Manifestation of Clonal Mast Cell Disorders. Current Allergy and Asthma Reports. https://doi.org/10.1007/s11882-014-0450-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.